Pharma Innovation Symphony: Delivery Technology Showcase – VB Salon Series Issues 35-38 on Drug Delivery

The development of drug delivery systems has evolved in tandem with innovative medical therapies, serving as a critical catalyst for translating foundational research into clinical applications and effectively benefiting patients. Delivery technologies not only influence therapeutic efficacy but have also become a decisive factor determining the success or failure of drug development.

With the emergence of innovative technologies, novel therapeutic modalities—including small-molecule drugs, antibody-based therapeutics, oligonucleotide drugs, and gene and cell therapies—are flourishing in tandem. These new treatment approaches give rise to fresh application challenges, such as enhancing the stability and convenience of antibody drugs, improving the in vivo delivery efficiency of nucleic acid therapeutics, and increasing the targeting precision of gene therapies. All of these demands call for continuous innovation in drug delivery technologies, turning scientific aspirations into clinical reality.

VCBeat and VCBeat New Pharma, in partnership with Shengshan Capital and industry allies, are jointly hosting a four-part monthly offline salon series titled “Symphony of Pharmaceutical Innovation: The Delivery Technology Awards.” The series will comprehensively explore the novel and elegant applications of viral vectors, non-viral vectors, conjugation technologies, and emerging drug delivery technologies in pharmaceutical R&D.

Epidemic Prevention Notice: Attendees must not have traveled to or resided in areas classified as medium- or high-risk within the past 14 days and must comply with the dynamic requirements issued by epidemic prevention authorities.